News

PHITEX 2026 Generates PHP 594.7 Million in Sales Leads, Up 20%

Image
PHITEX 2026 Generates PHP 594.7 Million in Sales Leads, Up 20%

Pasay City, Philippines – September 19, 2026 -- The Philippine Travel Exchange (PHITEX) 2026 closed with PHP 594,712,138.50 in sales leads, a 20.12 percent increase from the PHP 495.09 million recorded in 2025. The government-organized travel trade event, held at Conrad Manila, concluded on September 9.

Sunstone Hotel Investors to Report Q3 2026 Results Nov. 6

Aliso Viejo, Calif. – September 19, 2026 -- Sunstone Hotel Investors, Inc. (NYSE: SHO) will release its third quarter 2026 financial results on Friday, November 6, 2026, before market open.

Management sets conference call for 12:00 p.m. Eastern Time on results day

The lodging REIT's leadership team will host a quarterly conference call at 12:00 p.m. Eastern Time (9:00 a.m. Pacific Time) the same day to discuss the Q3 2026 performance with investors and analysts.

Company offers dual access via webcast and dial-in line

A live webcast will stream through the Investor Relations section of Sunstone's website, with a transcript archived afterward for reference. Investors can alternatively dial 1-833-461-5787 and reference Meeting ID 981 061 229 to join the live call.

Carestream Launches STARVIEW Digital Radiography System for Routine Imaging

Image
Carestream Launches STARVIEW Digital Radiography System for Routine Imaging

Shanghai – September 19, 2026 -- Carestream Healthcare International has launched the STARVIEW Digital Radiography System, a floor-mounted DR room built for routine radiographic imaging.

STARVIEW targets facilities upgrading from film, CR or aging DR systems

The system is designed to serve healthcare facilities introducing a first DR room, replacing legacy film-based or computed radiography equipment, or expanding routine-imaging capacity. Carestream built the platform around three pillars: fully digital operation, ease of adoption and scalability for future growth.

PBT Declares $0.0196 Unit Payout as Waddell Ranch Costs Persist

Dallas – September 19, 2026 -- Argent Trust Company, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT), declared a cash distribution of $0.019593 per unit, payable October 15, 2026, to unitholders of record September 30, 2026. The payout excludes any proceeds from the Waddell Ranch properties after production costs exceeded gross proceeds in August, extending a continuing excess cost position on those assets.

August Distribution Rises on Lower Trust Expenses

This month's per-unit distribution increased from the prior month primarily due to a decrease in Trust expenses. That gain was partially offset by lower oil and natural gas volumes and weaker oil pricing at the Texas Royalty Properties, even as natural gas pricing improved.

Cross Timbers Royalty Trust Declares $0.064277 September Distribution

Dallas – September 19, 2026 -- Cross Timbers Royalty Trust (NYSE: CRT) declared a cash distribution of $0.064277 per unit, payable October 15, 2026, to unitholders of record as of September 30, 2026.

Texas working interest costs climb by $277,000

Argent Trust Company, acting as Trustee, said XTO Energy reported that excess costs on properties underlying the Texas Working Interest net profits interests rose by $277,000. The increase did not reduce net proceeds from the Trust's remaining conveyances. Cumulative excess costs on the Texas Working Interest net profits interests now total $6,332,000, including $1,762,000 in accrued interest.

Virtusa Names Srinivas BG as New Board Chairman Effective Oct. 1

Image
Virtusa Names Srinivas BG as New Board Chairman Effective Oct. 1

Southborough, Mass. – September 19, 2026 -- Virtusa Corporation has appointed Srinivas BG as Chairman of its Board of Directors, effective October 1, 2026, succeeding Raj Mehta.

Virtusa taps 40-year industry veteran to lead board through AI-driven transformation

Srinivas BG brings more than 40 years of global leadership experience across the Information Technology, Telecommunications, Financial Services, and Manufacturing sectors. He previously held senior leadership roles at PCCW, Infosys, and ABB, where he managed multi-billion dollar business units, led large-scale acquisition integrations, and oversaw digital transformation programs.

Woodsboro Bank Names Mindy Kurz to Lead New Mt. Airy Branch

Image
Woodsboro Bank Names Mindy Kurz to Lead New Mt. Airy Branch

Frederick, Md. – September 19, 2026 -- Woodsboro Bank has appointed Mindy Kurz as Branch Manager of its new Mt. Airy branch, tapping a 30-year banking veteran to lead the community lender's expansion into Frederick County's Mt. Airy market.

Kurz brings three decades of branch leadership to the new post

Kurz most recently served as a Universal Banker, where she took on branch leadership duties while serving both consumer and business clients. Her background includes leading branch operations, developing teams, and building partnerships aimed at long-term community growth.

Tang Prize Honors CAR-T Pioneers Rosenberg, Sadelain, June in Taipei

Image
Tang Prize Honors CAR-T Pioneers Rosenberg, Sadelain, June in Taipei

Taipei – September 19, 2026 -- The 2026 Tang Prize Award Ceremony convened in Taipei on September 18, honoring six laureates across four categories including three scientists whose work led to FDA-approved CAR T-cell cancer therapies now used worldwide.

Three biopharmaceutical laureates trace a four-decade path from lab discovery to approved cancer drugs

Dr. Steven A. Rosenberg, who joined remotely, cited his team's work four decades ago showing that tumor-infiltrating lymphocytes (TILs) taken from patients' own tumors could drive cancer regression, establishing the concept of a patient's lymphocytes as a 'living drug.' That research laid groundwork for later T cell receptor (TCR) and chimeric antigen receptor (CAR) therapeutic strategies now deployed clinically.

mAbxience, Sandoz Partner on Emicizumab Biosimilar for Hemophilia A

Image
mAbxience, Sandoz Partner on Emicizumab Biosimilar for Hemophilia A

Madrid – September 19, 2026 -- mAbxience and Sandoz have signed a licensing, development, manufacturing and commercialization agreement for a proposed emicizumab biosimilar targeting hemophilia A, a treatment referencing Roche's Hemlibra with an estimated global reference market of USD 5.7 billion.

mAbxience will develop and manufacture the biosimilar at GMP facilities in Spain and Argentina

Under the agreement, mAbxience is responsible for development and manufacturing through its facilities in the two countries. Sandoz will handle global commercialization.

Sandoz secures exclusive global rights excluding three South American markets

Sandoz holds exclusive commercialization rights worldwide, with the exception of Argentina, Uruguay and Paraguay. Financial terms of the deal were not disclosed.

Hyperscale Data Declares Series D, Series E Preferred Stock Dividends

Image
Hyperscale Data Declares Series D, Series E Preferred Stock Dividends

Las Vegas – September 19, 2026 -- Hyperscale Data, Inc. (NYSE American: GPUS) declared monthly cash dividends of $0.2708333 per share on its 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock and $0.20833 per share on its 10.00% Series E Cumulative Redeemable Perpetual Preferred Stock.

Board sets record date of September 30, 2026 for dual preferred dividends

The record date for both dividend payments is September 30, 2026, with cash distributions scheduled for October 13, 2026. The payouts correspond to the 13.00% and 10.00% coupon rates set at issuance for the Series D and Series E preferred shares, respectively.